Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan 6;13(1):111-3.
doi: 10.1016/s0960-894x(02)00851-x.

Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B

Shuichi Asahi  1 , Shin-Ichiro Egashira, Masao Matsuda, Hisashi Iwaasa, Akio Kanatani, Mitsuru Ohkubo, Masaki Ihara, Hajime Morishima
Affiliations

Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B

Shuichi Asahi et al. Bioorg Med Chem Lett. .

Abstract

Investigation of L-alanine and D-amino acid replacement of orexin-B revealed that three L-leucine residues at the positions of 11, 14, and 15 in orexin-B were important to show selectivity for the orexin-2 receptor (OX(2)) over the orexin-1 receptor (OX(1)). L-Alanine substitution at position 11 and D-leucine substitution at positions 14 and 15 maintained the potency of orexin-B to mobilize [Ca(2+)](i) in CHO cells expressing the OX(2), while their potency for the OX(1) was significantly reduced. In combined substitutions, we identified that [Ala(11), D-Leu(15)]orexin-B showed a 400-fold selectivity for the OX(2) (EC(50)=0.13nM) over OX(1) (EC(50)=52nM). [Ala(11), D-Leu(15)]orexin-B is a beneficial tool for addressing the functional roles of the OX(2).

PubMed Disclaimer

LinkOut - more resources